Objective: This paper analyzes a series of ultrasound (US)-guided orbital fine needle aspirations (FNAs) which provide diagnostic information that cytopathologists approaching orbital lesions for the first time can find useful and underlines the importance of teamwork. Study Design: The investigators retrospectively obtained data from 24 consecutive orbital FNAs. For all patients, a complete clinicoradiological database was created. FNAs were performed under US guidance with 25-gauge needles and an aspiration biopsy syringe gun, and sent to the Department of Pathology for examination and data management. Results: The mean age of the patients was 54 years. Imaging studies included US, magnetic resonance imaging and computed tomography scans; 9 lesions involved the right orbit and 15 the left orbit. The mean lesion size was 23.6 ± 7.2 mm. After microscopic examination, 7 smears were labeled as ‘nondiagnostic', while in 17 cases a definitive diagnosis was proposed, which always proved to be correct (70.8%, specificity = 100%). Conclusions: The investigators believe that FNA biopsy of orbital masses is a necessary step; its weaknesses lie in the particularly delicate site of sampling and the extreme heterogeneity of lesions. Nevertheless, when orbital FNA is performed within a well-coordinated multidisciplinary team, it is a powerful tool that can be used to define the most appropriate management of these patients.

1.
Shields JA, Shields CL, Scartozzi R: Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery lecture. Part 1. Ophthalmology 2004;111:997-1008.
2.
Agrawal P, Dey P, Lal A: Fine-needle aspiration cytology of orbital and eyelid lesions. Diagn Cytopathol 2013;41:1000-1011.
3.
Singhal N, Mundi IK, Handa U, Punia RP, Mohan H: FNA in diagnosis of orbital lesions causing proptosis in adults. Diagn Cytopathol 2012;40:861-864.
4.
Chaudhry IA, Shamsi FA, Arat YO, Riley FC: Orbital pseudotumor: distinct diagnostic features and management. Middle East Afr J Ophthalmol 2008;15:17-27.
5.
Tailor TD, Gupta D, Dalley RW, Keene CD, Anzai Y: Orbital neoplasms in adults: clinical, radiologic, and pathologic review. Radiographics 2013;33:1739-1758.
6.
Pagni F, Jaconi M, Delitala A, et al: Incidental papillary thyroid carcinoma: diagnostic findings in a series of 287 carcinomas. Endocr Pathol 2014;25:288-296.
7.
Jaconi M, Pagni F, Vacirca F, et al: C-arm cone-beam CT-guided transthoracic lung core needle biopsy as a standard diagnostic tool: an observational study. Medicine (Baltimore) 2015;94:e698.
8.
Golden BA, Jaskolka MS, Ruiz RL: Craniofacial and orbital dermoids in children. Oral Maxillofac Surg Clin North Am 2012;24:417-425.
9.
Russin JJ, Rangel-Castilla L, Kalani MY, Spetzler RF: Surgical management, outcomes, and recurrence rate of orbital lymphangiomas. J Clin Neurosci 2015;22:877-882.
10.
Andrew NH, Sladden N, Kearney DJ, Selva D: An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD. Br J Ophthalmol 2015;99:376-381.
11.
Gupta N, Kaur J, Rajwanshi A, et al: Spectrum of orbital and ocular adnexal lesions: an analysis of 389 cases diagnosed by fine needle aspiration cytology. Diagn Cytopathol 2012;40:582-585.
12.
Andreoli MT, Aakalu V, Setabutr P: Epidemiological trends in malignant lacrimal gland tumors. Otolaryngol Head Neck Surg 2015;152:279-283.
13.
Kini YK, Halli R, Mishra S, Kalburge JV: Comprehensive management of a rare carcinoma ex pleomorphic adenoma of the lacrimal gland with a modified lateral orbitotomy access osteotomy. A case report. Oral Maxillofac Surg 2012;16:123-126.
14.
Sturgis CD, Silverman JF, Kennerdell JS, Raab SS: Fine-needle aspiration for the diagnosis of primary epithelial tumors of the lacrimal gland and ocular adnexa. Diagn Cytopathol 2001;24:86-89.
15.
Gerbino G, Boffano P, Benech R, et al: Orbital lymphomas: clinical and radiological features. J Craniomaxillofac Surg 2014;42:508-512.
16.
Catalfamo L, Nava C, Matyasova J, De Ponte FS: Primary diffuse large B-cell lymphoma of the ethmoido-orbital region. J Craniofac Surg 2013;24:e602-e604.
17.
Gupta R, Yadav JS, Yadav S, Wadood A: Orbital involvement in nonendemic Burkitts lymphoma. Orbit 2012;31:441-445.
18.
Shet T, Suryawanshi P, Epari S, Sengar M, Rangarajan V, Menon H, Laskar S: Extranodal natural killer/T cell lymphomas with extranasal disease in non-endemic regions are disseminated or have nasal primary: a study of 84 cases from India. Leuk Lymphoma 2014;55:2748-2753.
19.
Rubin PA, Remulla HD: Surgical methods and approaches in the treatment of orbital disease. Neuroimaging Clin N Am 1996;6:239-255.
20.
Tang W, Hei Y, Xiao L: Recurrent orbital space-occupying lesions: a clinicopathologic study of 253 cases. Chin J Cancer Res 2013;25:423-429.
21.
Nassar DL, Raab SS, Silverman JF, Kennerdell JS, Sturgis CD: Fine-needle aspiration for the diagnosis of orbital hematolymphoid lesions. Diagn Cytopathol 2000;23:314-317.
22.
Solo S, Siddaraju N, Srinivasan R: Use of fine needle cytology in the diagnosis of orbital and eyelid mass lesions. Acta Cytol 2009;53:41-52.
23.
Bhadauria M, Ranjan P, Mishra D: Primary orbital plasmacytoma mimicking lacrimal gland tumor. Orbit 2014;33:305-307.
24.
Evgeniou E, Menon KR, Jones GL, Whittet H, Williams W: Renal cell carcinoma metastasis to the paranasal sinuses and orbit. BMJ Case Rep 2012;2012:bcr0120125492.
25.
Tani E, Seregard S, Rupp G, Söderlund V, Skoog L: Fine-needle aspiration cytology and immunocytochemistry of orbital masses. Diagn Cytopathol 2006;34:1-5.
26.
Nair LK, Sankar S: Role of fine needle aspiration cytology in the diagnosis of orbital masses: a study of 41 cases. J Cytol 2014;31:87-90.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.